Susan Dillon

University of Glasgow — United Kingdom

Medicine · Health Sciences

10h-index617citations15works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Function and Risk Factors(5), Colorectal Cancer Surgical Treatments(4), Cardiac Imaging and Diagnostics(4), Colorectal Cancer Treatments and Studies(4), Colorectal and Anal Carcinomas(4)

Publications15 total

Durvalumab (MEDI 4736) with extended neoadjuvant regimens in rectal cancer: A randomized phase II trial (PRIME-RT).
Journal of Clinical Oncology·2022
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Radiation Oncology·2021Open Access
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Radiation Oncology·2021· 17 citedOpen Access
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT
Health Technology Assessment·2021· 29 citedOpen Access
Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial
The Lancet·2021· 137 citedOpen Access
Additional file 1 of Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Figshare·2021Open Access
Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2.
Journal of Clinical Oncology·2018· 35 cited
ACTR-22. RESULTS OF PHASE I OF THE PARADIGM TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH SHORT COURSE RADIOTHERAPY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Neuro-Oncology·2017· 4 citedOpen Access
FAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition
Annals of Oncology·2017· 2 citedOpen Access
Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog
Journal of the American College of Cardiology·2002· 101 cited
Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse
Journal of the American College of Cardiology·1995· 74 cited
The influence of obesity on left ventricular filling and systolic function
American Heart Journal·1992· 95 cited
The effect of exercise‐induced myocardial ischemia on postischemic left ventricular diastolic filling
Clinical Cardiology·1992· 19 cited
Left ventricular ejection fraction is increased during transesophageal echocardiography in patients with impaired ventricular function
American Heart Journal·1992· 15 cited
Two-dimensional transesophageal echocardiographic determination of aortic valve area in adults with aortic stenosis
American Heart Journal·1991· 89 cited

Frequent Co-authors

Caroline Kelly(6), Marcus F. Stoddard(5), Joel Kupersmith(4), Catherine Hanna(4), Séan M. O’Cathail(4), Janet Graham(4), Mark Saunders(4), Leslie Samuel(4), Lynsey Devlin(4), Joanne Edwards(4), Liz-Anne Lewsley(4), Noori Maka(4), Paula Morrison(4), Jacqueline Gourlay(4), Jonathan Platt(4), Fiona Thomson(4), Richard Adams(4), Mark Harrison(3), Daniel R. Gaya(3), Louise Dinnett(3)